Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Orchid Chemicals & Pharmaceuticals Ltd Announces Extension Of Financial Year For 2012-2013 Up To 18 Months


Wednesday, 26 Jun 2013 03:56am EDT 

Orchid Chemicals & Pharmaceuticals Ltd announced that the Board of Directors of the Company through circular resolution passed on June 24, 2013 have approved the extension of financial year 2012-2013 of the Company by a further period of 3 (three) months i.e. upto September 30, 2013. 

Latest Developments forOrchid Chemicals & Pharmaceuticals Ltd

Company Quote

50.5
-0.25 -0.49%
30 Apr 2015